22:48 , Dec 20, 2018 |  BC Extra  |  Company News

Management tracks: Evox names Moses chairman; Kapeller joins GV

Exosome therapy company Evox Therapeutics Ltd. (Oxford, U.K.) appointed Edwin Moses as chairman. This month, the former Ablynx N.V. CEO was also appointed chairman of Virion Biotherapeutics Ltd. (London, U.K.) and Achilles Therapeutics Ltd. (Stevenage,...
18:19 , Dec 7, 2018 |  BC Week In Review  |  Company News

Brii expands in infectious via deals with Vir, VBI, WuXi Biologics

Brii Biosciences (Shanghai, China) is broadening its pipeline in HBV and other infectious diseases through a series of new and expanded deals announced Dec. 6, even as CEO Zhi Hong said the company is looking...
13:00 , Dec 6, 2018 |  BC Extra  |  Company News

Brii expands in infectious via deals with Vir, VBI, WuXi Biologics

Brii Biosciences (Shanghai, China) is broadening its pipeline in HBV and other infectious diseases through a series of new and expanded deals announced Thursday, even as CEO Zhi Hong said the company is looking to...
03:01 , Sep 1, 2018 |  BioCentury  |  Politics, Policy & Law

A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
18:57 , Aug 31, 2018 |  BC Week In Review  |  Company News

Ping An to apply AI to healthcare ecosystem

Mobile health and wellness company Ping An Healthcare and Technology Co. Ltd. (HKSE:1833) partnered with pharmaceutical distributor Jointown Pharmaceutical Group Co. Ltd. (Shanghai:600998) to develop an AI-based healthcare and pharmacy system for use in Chinese...
22:00 , Aug 30, 2018 |  BC Extra  |  Company News

Ping An to apply AI to healthcare ecosystem

Mobile health and wellness company Ping An Healthcare and Technology Co. Ltd. (HKSE:1833) partnered with pharmaceutical distributor Jointown Pharmaceutical Group Co. Ltd. (Shanghai:600998) to develop an AI-based healthcare and pharmacy system for use in Chinese...
05:29 , Jun 2, 2018 |  BioCentury  |  Strategy

Partnering on a mission

With a $260 million war chest and a banner roster of execs, advisors and deals, Brii Biosciences is pushing an agenda to bring infectious diseases to the forefront of innovation in China. Its top priority...
18:22 , May 25, 2018 |  BC Week In Review  |  Financial News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on May 24 with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through...
12:24 , May 24, 2018 |  BC Extra  |  Company News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on Thursday with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization...
18:05 , May 11, 2018 |  BC Week In Review  |  Company News

GSK China, JD.com in healthcare access deal

The GSK China unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) signed a memorandum of understanding with Chinese retailer JD.com Inc. (NASDAQ:JD) on May 8 to collaborate on developing "Internet + Healthcare" solutions for improving healthcare access...